| API | Active pharmaceutical ingredient |
| BALB/c | Bagg albino mouse (inbred research mouse strain) |
| BMP-2 | Bone morphogenetic protein 2 (a subclass of TGF) |
| CCDC | Cambridge Crystallographic Data Centre |
| CD | Cyclodextrin |
| CNS | Central nervous system |
| DEN | Dengue virus |
| DIMEB | Heptakis-2,6-di-O-methyl-β-cyclodextrin |
| EMA | European Medicines Agency |
| FAO | Food and Agriculture Organization of the United Nations |
| FDA | Food and Drug Administration |
| FSGS | Focal segmental glomerulosclerosis |
| GRAS | Generally regarded as safe |
| H1N1 | Influenza virus type A subtype with hemmagluttinin 1 and neuraminidase 1 |
| HCV | Hepatitis C virus |
| HMPV | Human metapneumovirus |
| HPβCD | Hydroxypropylated-β-cyclodextrin (in random positions) |
| HPIV3 | Human parainfluenza virus type 3 |
| HSV-1 | Herpes simplex virus type 1 |
| IBV | Infectious bronchitis virus |
| IL-10 | Interleukin 10 |
| JECFA | Joint FAO/WHO Expert Committee on Food Additives |
| JEV | Japanese encephalitis virus |
| LAMP-1 | Lysosomal-associated membrane protein 1 |
| MDCK | Madin-Darby Canis familiaris kidney epithelial cell line |
| NDV | Newcastle disease virus |
| NPD | Niemann-Pick disease |
| NS1 | Non-structural protein 1 |
| RAMEB | Randomly methylated β-cyclodextrin |
| SIV | Simian immunodeficiency virus |
| TRIMEB | Heptakis-2,3,6-tris-O-methyl-β-cyclodextrin |
| TNF-α | Tumour necrosis factor alpha |
| U937 | Homo sapiens pleural myelomonocyte cell line |
| VZV | Varicela-zooster virus (chickenpox virus) |
| WHO | World Health Organisation |
| TGF-β1 | Transforming growth factor beta 1 (cytokine family) |